California’s leading epidemiologist, Dr. Erica S. Pan, reported severe allergic reactions and asked health care providers to stop using the batch of Moderna Chinese Communist Party (CCP) brand vaccine.
“A higher than usual number of possible allergic reactions were reported with a specific lot of the Moderna vaccine, administered at a community vaccination clinic,” Pan said according to local media outlet Your Central Valley, Jan. 17.
Health officials reported that those who received doses of the lot identified as 41L20A experienced severe side effects during the standard observation period.
“Out of an extreme abundance of caution and also recognizing the extremely limited supply of vaccine, we are recommending that providers use other available vaccine inventory,” Pan said as cases are investigated.
According to reports, more than 330,000 doses of this batch of vaccine had been distributed to 287 providers in California between Jan. 5 and Jan.12.
Along with the several undesirable reactions, deaths are also multiplying in several countries as the vaccination campaign progresses worldwide.
The development and production of vaccines against the CCP Virus in an extraordinarily short period raised suspicions.
Usually, several years of development and testing were necessary before previous vaccines were ready for use. The current adverse consequences seem to give reason to those who noticed this inconsistency.
There are already several dozen deaths reported, including 55 in the United States and 29 in Norway, in addition to hundreds of hospitalizations and thousands of medical emergencies.
Other deaths have been recorded in Israel, Sweden, Portugal, and Switzerland.
According to Bloomberg, most of those vaccinated suffered side effects such as nausea, vomiting, fever, local reactions at the injection site, and the worsening of their underlying condition.
Both Moderna’s and Pfizer-BioNTech’s products show undesirable side effects.
Also of concern is the Sinovac brand of vaccines produced in laboratories linked to the CCP that barely exceed the 50% effectiveness threshold.
The Butantan Institute of Brazil reported this on Jan. 15, where only 50.4% effectiveness was observed.
According to Reuters, the CCP vaccine, known as CoronaVac, causes concern because the drugs developed in China are not subject to the same scrutiny as the American and European alternatives.
Sinovac also has a history of offering bribes to CCP officials responsible for approving its products.
According to data, there were already 3,916 adverse events in the United States in December, including 13 deaths, which could deter people from taking the vaccines, according to the organization Children’s Health Defense.
“The CDC’s conservative estimate of the anaphylaxis rate for experimental COVID-19 mRNA vaccines is roughly 10 times greater than for flu shots, including in individuals with no prior history of allergic reactions,” added Children’s Health Defense.”